Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04393415
Other study ID # covid -19
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 25, 2020
Est. completion date September 1, 2020

Study information

Verified date July 2020
Source Aljazeera Hospital
Contact Mahmoud Alalfy, PhD
Phone 01002611058
Email mahmoudalalfy@ymail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

covid - 19 is a critical viral infection that affects humans


Description:

Covid -19 pandemic started was declared in 2020


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date September 1, 2020
Est. primary completion date August 25, 2020
Accepts healthy volunteers No
Gender All
Age group 20 Years to 70 Years
Eligibility Inclusion Criteria:

- patients with positive covid -19 and has symptoms and isolated in the hospital

Exclusion Criteria:

- patients with negative test for covid -19

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
stem cells
giving stem cells to patients with covid - 19

Locations

Country Name City State
Egypt Aljazeera( Al Gazeera) hospital Giza

Sponsors (1)

Lead Sponsor Collaborator
Aljazeera Hospital

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary the number of patients with positive covid 19 who will improve after receiving stem cells patients with positive covid 19 who will improve after receiving stem cells 2 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03911388 - HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors Phase 1
Recruiting NCT06059027 - Microbes and Respiratory Illnesses
Completed NCT03463694 - Edinburgh and Lothian Virus Intervention Study in Kids N/A
Not yet recruiting NCT05387226 - Intravenous Injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell Lymphoma Phase 1
Active, not recruiting NCT05064462 - TTV Viral Load in Heart Transplant Recipients
Recruiting NCT04336020 - The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) Study
Recruiting NCT05727709 - Dynamic Changes of Torquetenovirus (TTV) Load in Chinese Renal Transplant Recipients
Recruiting NCT04382131 - Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19) N/A
Completed NCT02743663 - The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children
Not yet recruiting NCT06396624 - Effects of Photobiomodulation on the Innate Immune System of Neonates and Infants With Bronchiolitis N/A
Not yet recruiting NCT06432855 - Genetic Determinants of the Antiviral Immune Response in Oceanian Populations N/A
Not yet recruiting NCT05868551 - Onchocerciasis-Associated Epilepsy, an Explorative Case-control Study
Completed NCT01136395 - Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation Phase 2
Completed NCT01159561 - Western Equine Encephalitis Vaccine, Inactivated Phase 1
Completed NCT04636294 - Borderline COVID-19 PCR Test Result
Recruiting NCT04449978 - TARGet Kids! COVID-19 Study of Children and Families
Recruiting NCT06135844 - Hand Sanitizer Use for Herpes Simplex Virus-1 Early Phase 1
Recruiting NCT04348864 - COVID-19 Diagnostic Self-testing Using Virtual Point-of-care N/A